different types of semaglutides Semaglutide for Weight Loss: How It Works, Comparisons, and More Wegovy vs. Ozempic: What To

Schedule and Convenience: The Real Trade-off This is where the two drugs differ most obviously

Most people begin noticing weight changes between 4 and 12 weeks of consistent use

Key FDA guidance: Incremental weight loss (enobosarm + GLP-1 versus GLP-1 alone) is an acceptable primary endpoint for approval The 3 mg dose is appropriate for continued development FDA encouraged including younger patients, not just older populations Phase 2 QUALITY study data: 16 weeks of enobosarm in older patients taking semaglutide Preserved lean mass and burned additional fat mass Improved physical function During the maintenance period (12 weeks after semaglutide discontinuation), enobosarm prevented weight regain by 46% compared to placebo Next steps : Veru plans to initiate the Phase 2b PLATEAU trial in Q1 2026, enrolling approximately 180 patients (both older and younger) with obesity taking tirzepatide

Communicate the timeline to your partner

However, Saini notes that fiber intake should be individualized based on a clients tendency to get diarrhea or other digestive issues

GLP-1 increases insulin secretion, decreases glucagon secretion, and slows gastric emptying, leading to a reduction in blood glucose levels